As 2012 nears its end, the rear-view mirror is full of ups and downs in the health care sector. One company that had plenty of both is small-cap Spectrum Pharmaceuticals. Here are the major milestones ...

BOSTON--(BUSINESS WIRE)--Spectrum Pharmaceuticals, Inc. (NasdaqGS: SPPI), a biopharmaceutical company focused on novel and targeted oncology therapies, today announced that the U.S. Food and Drug ...

Spectrum Pharmaceuticals, Inc., et al., No. 1:22-cv-10292 (S.D.N.Y.) re-opened the lead plaintiff process and set September 24, 2025 as the deadline for investors to seek appointment as the new lead ...

HENDERSON, Nev.--(BUSINESS WIRE)--Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biopharmaceutical company focused on novel and targeted oncology therapies, today announced that an inspection of the ...

May 4 (Reuters) - Spectrum Pharmaceuticals Inc. said it has agreed to raise about $32 million in a direct offering of about 5.1 million shares of common stock at $6.25 a share. The company said it ...

PHILADELPHIA, Sept. 8, 2025 /PRNewswire/ -- National plaintiffs' law firm Berger Montague PC is investigating securities fraud claims against Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) ("Spectrum" ...

SAN FRANCISCO, CA / ACCESS Newswire / September 24, 2025 / A New York federal court has re-opened the lead plaintiff process in the Spectrum Pharmaceuticals (SPPI) securities class action. This ...

Shares of Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) are losing ground after the oncology-focused biotech's fourth-quarter earnings failed to impress on two fronts. The company's commercial-stage ...

SAN FRANCISCO, Sept. 18, 2025 /PRNewswire/ -- A New York federal court has re-opened the lead plaintiff process in the Spectrum Pharmaceuticals (SPPI) securities class action. This development offers ...

April 23 (Reuters) - Spectrum Pharmaceuticals Inc said it expects to seek U.S. marketing approval for its blood cancer drug in the third quarter, after the treatment was shown to be safe and effective ...